While starting with lower doses of GIP/GLP-1 medications such as Mounjaro and Wegovy, you may still experience feelings of hunger, especially if you have previously been used to using weightloss medications. These treatments are initiated at a low dose to minimise side effects and allow your body to adjust to the medication. As your dosage increases, you should notice a more significant reduction in hunger. The full appetite-suppressing effects generally become more apparent once you are closer to or at the maintenance doses.
For optimal results with GIP/GLP-1 treatments, consider transitioning to a diet rich in whole foods, which include unprocessed proteins, healthy fats, and high-fibre carbohydrates. This can help stabilise blood sugar levels and enhance the fullness effect provided by the medication, making it easier to manage your appetite and achieve your health goals.